The risk of drug-eluting stent thrombosis with noncardiac surgery

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Abstract

Patients in whom any kind of stent, particularly a drug-eluting stent (DES), was recently implanted are at risk for stent thrombosis when they undergo noncardiac surgery, even months or years after their implantation. The risk of DES thrombosis is likely decreased by delaying noncardiac surgery for as long as possible and continuing dual or at least single antiplatelet therapy in the perioperative period. Preoperative identification and close monitoring of patients with DES may allow prevention and prompt detection and treatment of this catastrophic complication.

Original languageEnglish (US)
Pages (from-to)406-411
Number of pages6
JournalCurrent Cardiology Reports
Volume9
Issue number5
DOIs
StatePublished - Sep 1 2007

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The risk of drug-eluting stent thrombosis with noncardiac surgery'. Together they form a unique fingerprint.

Cite this